Sector: Healthcare|Industry: Medical Distribution|Market Cap: $72.48B|Employees: 51K
McKesson Corporation is a diversified healthcare services leader that partners with biopharma companies, care providers, pharmacies, manufacturers, and governments to deliver insights, products, and services to make quality care more accessible and affordable. The company operates in four segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International. McKesson's key markets include the U.S., Canada, and Europe, with a focus on supply chain excellence and innovative solutions.
Revenues increased by 6% year-over-year, primarily driven by a 7% increase in the U.S. Pharmaceutical segment due to growth in specialty pharmaceuticals and higher volumes from retail national account customers. Total revenues reached $79.283 billion.
Gross profit margin decreased slightly from 4.06% to 3.98% year-over-year, despite a 4% increase in gross profit to $3.152 billion. This decrease is primarily due to changes in product mix and pricing dynamics.
Net income attributable to McKesson Corporation decreased by 4% year-over-year, from $958 million to $915 million. This decrease is primarily due to a rise in operating expenses and a decrease in other income.